Leave a message

Interrelation between Rheumatic Autoimmune Disease, Autohemolitic Anemia and Cancer Arising as Epiphenomenon on Paraneoplastic Syndrome

Research Article | DOI: https://doi.org/10.31579/2690-4861/169

Interrelation between Rheumatic Autoimmune Disease, Autohemolitic Anemia and Cancer Arising as Epiphenomenon on Paraneoplastic Syndrome

  • Dejan Spasovski 1*
  • Emilija Sandevska 1
  • Svetlana Krsetvska-Balkanov 2

1 University Clinic for Rheumatology, Clinical Center “Mother Therese”, Skopje, Republic of North Macedonia.

2 University Clinic of Hematology, Clinical Center “Mother Therese”, Skopje, Republic of North Macedonia.

*Corresponding Author: Dejan Spasovski, University Clinic of Rheumatology, University Clinical Center – Mother Therese, Skopje, Republic of North Macedonia.

Citation: D Spasovski, E Sandevska, Svetlana K Balkanov. (2021). Multiple Sclerosis and Chlamydia. International Journal of Clinical Case Reports and Reviews. 9(1); DOI:10.31579/2690-4861/169

Copyright: © 2021 Dejan Spasovski, This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Received: 23 August 2021 | Accepted: 12 November 2021 | Published: 23 November 2021

Keywords: rheumatic autoimmune disease; autohemolitic anemia; cancer; epiphenomenon; paraneoplastic syndrome

Abstract

There are hemolytic anemias of different origin. For instance, these states may be induced by me­ans of so­­me exogenic hemolytic factors: by different organic and unorganic hemolytic toxins (phospho­rus, phe­nyl­hydrazin, saponins, arsenicum, lead and biotoxins – snake venom, mushroom poisons, mycotoxins, etc.), so­me medical preparations, radiations, some infectious agents and haevy burns. Besides, in some ca­ses, he­molytic anemias are induced by antibodies and immunocompetent cells against own tissues (auto­immune hemolytic anemia).

Introduction

There are hemolytic anemias of different origin. For instance, these states may be induced by me­ans of so­­me exogenic hemolytic factors: by different organic and unorganic hemolytic toxins (phospho­rus, phe­nyl­hydrazin, saponins, arsenicum, lead and biotoxins – snake venom, mushroom poisons, mycotoxins, etc.), so­me medical preparations, radiations, some infectious agents and haevy burns. Besides, in some ca­ses, he­molytic anemias are induced by antibodies and immunocompetent cells against own tissues (auto­immune hemolytic anemia). 

Reason of immunization of autoimmune hemolytic anemias may be some infection diseases (malaria, grippe, pneumonias, i.e. viruses, bacteria, acu­te anaerobic or streptococcal sepsis, my­co­plasma pneumoniae,) and so­me chemical and physical factors and influences.

There is a relationship between B-cell oncogenesis and autoimmunity disease.

According to clinical stu­dies malignant tumors in autoimmune hemolytic anemias appear in 45-47%. Obser­vation of a large body of lite­rature, permit to suggest that quite frequently tumor cells in autoimmune he­­­­­mo­lytic anemias have lym­phoid and macrophagal nature.The analysis of 234 patients with autoimmune he­­­­mo­lytic ane­­mias sho­wed chronic lympho­leukemias, malignant lymphomas, multiple myelomas, alimen­tary tract cancers and so on [1]. The analysis of 168 patients with hemolytic anemias showed ap­pro­xi­mately si­milar results [2]. The in­cidence of tumors of this localization and histogenesis increases sig­ni­fi­cantly du­ring such human au­to­immune diseases as systemic lupus erythematosus, rhematoid arthritis, etc. [3-5].

Some viruses, like grippe, rubella, HIV, and some carcinogenic agents can induce fussion and at the soma time cytolitic effect in somatic cell [6, 7].

For in­s­tance, toxin of Aspergillus flavus – af­­la­to­xin, together with he­a­vy toxic action, induces malignant tu­mors (hepatomas) of the liver. Such dif­fe­rent effects of these agents on somatic cells possibly depend on the size of plasma membranes’ pores in­duced by them.

For instance, hi­gh doses of carcinogenic agents lead to partial in­creasing of quantity of giant polynuclear cells, but further increase of this dose induces massive cellular ly­sis. In low doses of carcinogenic agents, dikaryons (cells, with comparatively high oncogenic po­ten­cy) are ob­ser­ved most frequently. 

Larger perforations induce considerable dest­ruc­ti­on of cell membranes and following cytolysis together with the perishing of these cells [8].

There are some assumptions about the as­sociation of Vipera le­be­tina bites with the development of cancer of different localization and his­to­ge­ne­sis. For instance, after bite of snake with he­molytic action of venom (Vipera le­be­t­i­na, Vi­pera Russellii, etc.) together with massive destruction of erythrocytes hemolysis. Some Fungus toxins, like Aspergillus ochra­ce­us, Aspergillus fla­vus, Penicillium islandicum,may give some similar action. 

In our opinion, the mechanism of malignant transformation in autoimmune reactions can be based on the inclusion of immunocompetent cells in different cellular cooperations, which is their normal physio­lo­­gical property. 

As it is shown, in case of autoimmune hemolytic anemia or allotransplantations, the macro or­ga­ni­sm reacts to the modificated (foreign) cells by development of humoral and cel­lu­­lar immune responses (im­m­une cy­to­lysis). In the development of cytolysis the most im­portant roles are played by specific antibodies and T-killer (cytotoxic) cells (immune effectors). 1. An­ti­bo­dy mo­lecules have 2 main functions: they bind to the im­­mu­­no­genic antigens and after interaction with these antigens, initiates invol­ve­ment of dif­ferent cells and molecules. The constant region (C region) of the antibodies defines the type of the res­ponse af­ter the anti­bo­dy-antigen interaction, whether this is complement-me­di­ated lysis, cellular cytotoxicity, en­han­ced pha­go­cytosis, etc. 2. The ce­ll-im­mune cytolysis is carried out directly by the killers (T-cy­to­toxic cel­ls).The cy­totoxic effect of these cells is realized in the target cells plasmalemma by spe­cial proteins – pe­r­fo­rins which lead to the formation in this organoidThis cells generate substances of cy­to­to­xic and cy­to­lytic action, causing thus cell necrosis with disintegration of its plasma­lem­ma or induction of apo­ptosis. Perforins (together with gran­zymes and granulolyzins) are localized in killer cells (mac­ro­phages, T-lym­phocytes, NK-cells) granules. In the pre­sen­ce of calcium, perforines in­teract wi­th the plasmatic mem­b­rane of the target cells and after the poly­me­rization they are forming the trans­membrane channels (pores) in this organoid. In the case of great number or size, these pores induce the cells destruction or other cy­to­pa­thogenic effects. So both, cy­totoxic cells and antibodies can induce dama­ges of some de­­g­­­ree plasma membranes in somatic cell. This condition can represent as precan­ce­rous state and later the true can­ce­rous cells formation [9, 10].                                                                  

Target cell killing is carried out in several phases: 1) contact with killer-target-cell; 2) activation on killer cell; 3) killer cell make exo­cy­tosis of this toxic substances; and 4) toxic effect directed on target cell. Thus, pore-for­­­­mi­ng enzyme, antibodies, peptids, etc. cause plasma membrane damage in target cells, with con­se­quen­ces as diverse as proliferation or cell destruction.

Supposing that leucocytes (in this concrete case, lymphocytes and macrophages) are pheno­typi­cally dominant cells, their fusion with each other and with other somatic cells may lead to tumor formation of lymphoid and macrophagal nature. Carcinogenic agents and even infectious viruses and bacterial memb­rano­to­xins may induce both fusion and hemolytic effects in somatic cells simultaneously. In au­to­mphoid and macrophagal nature. im­mune he­­mo­ly­tic anemias side by si­de with hemolysis it may take place process of somatic cells fusion with furt­her for­ma­tion of tumor cells. 

Thus, cell fusion may in some cases of autoimmune process produce a cell with tumor properties. Carcinogenic agents or some other reasons (immunocompetent cells, antibodies) may create the auto­im­mu­nization background in a macro organism, which may lead to multiple intercellular contacts between im­mu­­no­competent cells and cells with aberrant antigens. In case of cells fusion, initiation of malignant neo­plas­ms of lymphoid or macrophagal histogenesis is expected to take place. 

As a possible cellular mechanism of malignization in hemolytic anemias of different origin is proces of fusion of immunocompetent cell with other ones. 

All the more that, formation of hybrid cells in vivo, it is possible consider as an physiological phenomenon.

References

a